Mardil Medical Inc. has completed a pair of first-in-human implants of its combination therapy Ventouch Triad device at Sanitorio Italiano in Asunción, Paraguay, among patients with type IIIb functional mitral valve regurgitation (FMR). The Ventouch Triad is designed to treat both the dilated ventricle and affected valve in FMR patients who often experience exacerbated heart failure without treatment. Read More
